# Dietary Fish Oil Intervention in Polycystic Ovary Syndrome (PCOS)

> **NCT04116203** · PHASE1 · COMPLETED · sponsor: **University of Alberta** · enrollment: 52 (actual)

## Conditions studied

- Polycystic Ovary Syndrome
- Lipid Metabolism Disorders

## Interventions

- **DRUG:** Metformin
- **COMBINATION_PRODUCT:** Fish Oil and Metformin
- **DIETARY_SUPPLEMENT:** Fish Oil

## Key facts

- **NCT ID:** NCT04116203
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-30
- **Primary completion:** 2020-11-12
- **Final completion:** 2020-11-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-02-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04116203

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04116203, "Dietary Fish Oil Intervention in Polycystic Ovary Syndrome (PCOS)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04116203. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*